Kejia Xu

1.1k total citations · 1 hit paper
30 papers, 838 citations indexed

About

Kejia Xu is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Kejia Xu has authored 30 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Computational Theory and Mathematics. Recurrent topics in Kejia Xu's work include Cancer Cells and Metastasis (5 papers), Bioinformatics and Genomic Networks (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Kejia Xu is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Bioinformatics and Genomic Networks (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Kejia Xu collaborates with scholars based in China, Australia and United States. Kejia Xu's co-authors include Jianliang Shen, Yuna Qian, Yujing Zheng, Mali Dai, Xuan Wu, Juan Jin, Qiang Niu, Hui Zheng, Xiaojun He and Jiangning Song and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and Cancer Research.

In The Last Decade

Kejia Xu

26 papers receiving 834 citations

Hit Papers

Immunoregulation in Diabe... 2022 2026 2023 2024 2022 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kejia Xu China 13 336 233 189 184 72 30 838
Xuan Wu China 11 339 1.0× 228 1.0× 315 1.7× 184 1.0× 69 1.0× 35 1.2k
Xiaoqi Jiang Germany 10 221 0.7× 142 0.6× 238 1.3× 237 1.3× 34 0.5× 19 802
Praveen Kolimi United States 14 189 0.6× 233 1.0× 240 1.3× 140 0.8× 37 0.5× 18 865
Ye Yang China 21 248 0.7× 459 2.0× 337 1.8× 282 1.5× 25 0.3× 55 1.2k
Xiangyu Chu China 16 166 0.5× 105 0.5× 305 1.6× 130 0.7× 26 0.4× 32 783
Qiuju Li China 10 303 0.9× 241 1.0× 133 0.7× 110 0.6× 40 0.6× 13 707
Xiaojing Chen China 14 95 0.3× 107 0.5× 172 0.9× 170 0.9× 52 0.7× 35 716
Christopher Dunnill United Kingdom 6 551 1.6× 253 1.1× 184 1.0× 169 0.9× 44 0.6× 9 1.1k
Ioannis D. Karantas Türkiye 11 218 0.6× 250 1.1× 84 0.4× 129 0.7× 53 0.7× 18 650

Countries citing papers authored by Kejia Xu

Since Specialization
Citations

This map shows the geographic impact of Kejia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejia Xu more than expected).

Fields of papers citing papers by Kejia Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejia Xu. The network helps show where Kejia Xu may publish in the future.

Co-authorship network of co-authors of Kejia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kejia Xu. A scholar is included among the top collaborators of Kejia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kejia Xu. Kejia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Kejia, et al.. (2025). Gut microbes of the cecum versus the colon drive more severe lethality and multi-organ damage. International Immunopharmacology. 147. 114029–114029. 1 indexed citations
2.
Xu, Kejia, et al.. (2024). Phosphatidylserine improves aging sepsis survival, modulates gut microbiome, and prevents sepsis-associated encephalopathy. Biomedicine & Pharmacotherapy. 178. 117200–117200. 7 indexed citations
3.
Wang, Xiaoxue, Kejia Xu, Beilei Zeng, et al.. (2024). Novel EGFR inhibitors against resistant L858R/T790M/C797S mutant for intervention of non-small cell lung cancer. European Journal of Medicinal Chemistry. 277. 116711–116711. 17 indexed citations
4.
Guo, Hao, Kejia Xu, Quan Liu, et al.. (2024). Discovery of novel fructose-1,6-bisphosphatase inhibitors bearing benzimidazole scaffold using a dual-ligand molecular docking model. European Journal of Medicinal Chemistry. 279. 116888–116888.
5.
Xu, Kejia, et al.. (2024). Update on protease-activated receptor 2 in inflammatory and autoimmune dermatological diseases. Frontiers in Immunology. 15(2). 88–95.
6.
Xu, Kejia, et al.. (2023). Machine learning algorithms to predict intraoperative hemorrhage in surgical patients: a modeling study of real-world data in Shanghai, China. BMC Medical Informatics and Decision Making. 23(1). 156–156. 5 indexed citations
7.
8.
Qian, Yuna, Yujing Zheng, Juan Jin, et al.. (2022). Immunoregulation in Diabetic Wound Repair with a Photoenhanced Glycyrrhizic Acid Hydrogel Scaffold. Advanced Materials. 34(29). e2200521–e2200521. 544 indexed citations breakdown →
9.
10.
Xu, Kejia, Hui Li, Qiong Huang, et al.. (2022). Integrated transcriptomics and metabolomics analysis of the hippocampus reveals altered neuroinflammation, downregulated metabolism and synapse in sepsis-associated encephalopathy. Frontiers in Pharmacology. 13. 1004745–1004745. 14 indexed citations
11.
Zhang, Guangming, Zelin Lai, Kejia Xu, et al.. (2021). Delta Opioid Receptor Activation with Delta Opioid Peptide [d-Ala2, d-Leu5] Enkephalin Contributes to Synaptic Improvement in Rat Hippocampus against Global Ischemia. Cell Transplantation. 30. 4211099441–4211099441. 5 indexed citations
12.
Chen, Xiaosu, Kejia Xu, Xiaoshuang Wang, et al.. (2021). DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma. Cancers. 13(6). 1403–1403. 13 indexed citations
13.
Xu, Kejia, et al.. (2018). Propofol prevents IL‐13‐induced epithelial–mesenchymal transition in human colorectal cancer cells. Cell Biology International. 42(8). 985–993. 20 indexed citations
14.
Xu, Kejia, Jiangning Song, & Xing‐Ming Zhao. (2012). The drug cocktail network. BMC Systems Biology. 6(S1). S5–S5. 25 indexed citations
15.
Wang, Yin‐Ying, Kejia Xu, Jiangning Song, & Xing‐Ming Zhao. (2012). Exploring drug combinations in genetic interaction network. BMC Bioinformatics. 13(S7). S7–S7. 30 indexed citations
16.
Wang, Kai, Kejia Xu, Hua Cheng, et al.. (2011). CASCADE_SCAN: mining signal transduction network from high-throughput data based on steepest descent method. BMC Bioinformatics. 12(1). 164–164. 15 indexed citations
17.
Zheng, Yonghong, et al.. (2011). A Novel Method of Image Segmentation Based On Gradient Inhibiting PCNN. Energy Procedia. 13. 3445–3453. 1 indexed citations
18.
Xu, Kejia, Jiangning Song, & Xing‐Ming Zhao. (2010). A Network Biology Approach to Understand Combination of Drugs. 347–354. 2 indexed citations
19.
Suo, Zhenhe, et al.. (2009). [Quantity and distribution of CD44+/CD24- cells in breast cancer tissue and the cell lines].. PubMed. 38(7). 441–4. 4 indexed citations
20.
Li, Huixiang, et al.. (2009). MUC-1-/ESA+ progenitor cells in normal, benign and malignant human breast epithelial cells.. PubMed. 24(11). 1381–90. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026